CROSSTALK BETWEEN ARYL HYDROCARBON RECEPTOR (AHR) AND BCL-2 PATHWAYS SUGGESTS THE USE OF AHR ANTAGONIST TO MAINTAIN NORMAL DIFFERENTIATION STATE OF MAMMARY EPITHELIAL CELLS DURING BCL-2 INHIBITION THERAPY

Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy

Introduction: Activating the aryl hydrocarbon receptor upon exposure to environmental pollutants promotes development of breast cancer stem cell (CSCs).BCL-2 family proteins protect cancer cells from the apoptotic effects of chemotherapeutic drugs.However, the crosstalk between AhR and the BCL-2 family in CSC development remains uninvestigated.Obje

read more



Guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance in Japan: A tiered approach for the assessment of clinically meaningful driving impairment

Abstract In December 2022, the Ministry of Health, Labour and Welfare (MHLW) of Japan issued and implemented the guideline for evaluating the effects of psychotropic drugs on motor vehicle driving performance.This guideline recommends the use of a tiered approach to assess clinically meaningful driving impairment.It is noted Protection that adverse

read more